Corvus Pharmaceuticals, Inc. (CRVS)

17.90 +0.37 (+2.11%) USD  |  NASDAQ  |  Mar 04, 13:39
More

Corvus Pharmaceuticals Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. --
Jaguar Health, Inc. Upgrade
Krystal Biotech, Inc. Upgrade